# Tight Spaces, Big Discoveries: Decoding Human Adhesion Biology with Avian Chorioallantoic Membrane Xenograft Models

## TL;DR

This paper reviews how the chick chorioallantoic membrane model helps study tight junction proteins' roles in cancer, offering a fast and ethical alternative to traditional models.

## Contribution

The paper introduces the CAM model as a novel, ethically viable system for studying tight junction proteins in cancer progression and therapy.

## Key findings

- The CAM model allows rapid observation of tumor growth and vascular interactions.
- Tight junction proteins influence cancer progression through tissue structure and signaling pathways.
- Combining CAM with imaging and genetic tools improves insights into cancer biology.

## Abstract

Tight junction proteins, including JAM-A, claudins, and occludin, are known for maintaining tissue barriers, but they also influence how cancers grow, spread, and respond to treatment. Studying these proteins in living systems requires models that are realistic, fast, and ethically responsible. The chick chorioallantoic membrane (CAM) model offers a cost-effective way to observe tumour growth, blood vessel formation, and interactions with surrounding tissue in a short timeframe. This review highlights how the CAM model can help researchers understand the role of tight junction proteins in cancer progression, including their effects on tissue structure, cell signalling, and tumour invasiveness. By combining this model with new imaging techniques, genetic tools, and patient-derived samples, scientists can gain faster and more detailed insights into cancer biology. Using the CAM alongside traditional rodent models could improve preclinical research and support the development of new therapies targeting tight junction proteins.

Tight junction (TJ) proteins, such as Junctional Adhesion Molecule-A (JAM-A), claudins, and occludin, play increasingly recognized roles in cancer biology beyond their structural functions, influencing tumour proliferation, invasion, metastasis and therapy resistance. Understanding how these proteins modulate tumour progression in vivo requires models that are both physiologically relevant and ethically viable. The chick chorioallantoic membrane (CAM) xenograft model has emerged as a powerful and cost-effective in vivo system that aligns with the 3Rs (replacement, reduction, and refinement), offering unique advantages such as vascular accessibility, rapid tumour growth kinetics and immunotolerance. This review explores how the CAM model can be leveraged to study the mechanistic role of TJ proteins in tumour–stroma interactions, angiogenesis, extracellular matrix (ECM) remodelling and mechanotransduction, including the YAP/TAZ pathway. While limitations remain, particularly with respect to immune modelling and long-term studies, recent advances in imaging, genetic manipulation and integration of patient-derived xenografts (PDXs) are expanding the model’s translational relevance. Standardizing methodologies and embracing new molecular tools will further elevate the utility of this approach as a complementary platform to traditional rodent models, with significant promise for TJ-focused cancer research and therapeutic innovation.